PNEUMONIA
Clinical trials for PNEUMONIA explained in plain language.
Never miss a new study
Get alerted when new PNEUMONIA trials appear
Sign up with your email to follow new studies for PNEUMONIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibiotic tackles tough infections in vulnerable patients
Disease control TerminatedThis study tested the antibiotic ceftolozane-tazobactam for serious Pseudomonas aeruginosa infections in people with blood cancers or who had a stem cell transplant. Participants received the drug through a vein for 10 to 14 days. Researchers tracked whether patients were alive a…
Matched conditions: PNEUMONIA
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
Experimental drug auxora tested in severe COVID-19 pneumonia – study halted early
Disease control TerminatedThis study tested a drug called Auxora in 10 critically ill patients with COVID-19 pneumonia who were on ventilators. The main goal was to see how the drug affected immune cells in the lungs and to check its safety. The study was terminated early, so results are limited.
Matched conditions: PNEUMONIA
Phase: PHASE2 • Sponsor: CalciMedica, Inc. • Aim: Disease control
Last updated May 11, 2026 20:51 UTC
-
Smart band tracks COVID-19 breathing trouble
Knowledge-focused TerminatedThis study tested a special band called AirGo that monitors breathing in COVID-19 patients with respiratory failure. Researchers wanted to see if the band could detect patterns of worsening breathing early. The study included 25 hospitalized adults with COVID-19 who were breathin…
Matched conditions: PNEUMONIA
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC